Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.55 USD
-0.03 (-5.09%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.55 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -9.91 |
EPS Last Quarter | -5.75 |
Last EPS Surprise | 65.38% |
ABR | 1.00 |
Earnings ESP
|
-29.11% |
---|---|
Current Year | -34.73 |
Next Year | -16.59 |
EPS (TTM) | -177.32 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.30M | 3.38M | 12.97M | 18.08M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 3.80M | 3.80M | 13.90M | 20.15M |
Low Estimate | 2.80M | 2.95M | 12.03M | 16.00M |
Year ago Sales | 0.00M | 3.99M | 7.77M | 12.97M |
Year over Year Growth Est. | NA | -15.41% | 66.90% | 39.41% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -9.91 | -7.37 | -34.73 | -16.59 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -12.80 | -9.30 | -43.90 | -17.20 |
High Estimate | -7.03 | -5.43 | -25.56 | -15.97 |
Low Estimate | -12.80 | -9.30 | -43.90 | -17.20 |
Year ago EPS | -85.62 | -58.47 | -218.85 | -34.73 |
Year over Year Growth Est. | 88.43% | 87.40% | 84.13% | 52.24% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -9.91 | -7.37 | -34.73 | -16.59 |
7 Days Ago | -9.91 | -7.37 | -34.73 | -16.59 |
30 Days Ago | -8.15 | -7.03 | -30.51 | -19.17 |
60 Days Ago | -8.15 | -7.03 | -30.51 | -19.17 |
90 Days Ago | -7.03 | -5.75 | -55.75 | -38.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -12.80 | -9.30 | -43.90 | -17.20 |
Zacks Consensus Estimate | -9.91 | -7.37 | -34.73 | -16.59 |
Earnings ESP | -29.11% | -26.26% | -26.40% | -3.70% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -5.75 | -27.48 | -58.47 | -85.62 | NA |
Estimate | -16.61 | -49.84 | -47.60 | -88.82 | NA |
Difference | 10.86 | 22.36 | -10.87 | 3.20 | 6.39 |
Surprise | 65.38% | 44.87% | -22.82% | 3.60% | 22.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more